 |
 |
 |
Journal articles
A Case-report of Unpredictable and Massive Voriconazole Intoxication in a Patient with Extensive CYP2C19 and CYP2C9 Polymorphisms.
Abstract : This case-report describes a massive voriconazole (VRZ) intoxication in a patient with a poor metabolizer profile, highlighted by low plasma main metabolite concentrations (N-oxide voriconazole), despite an extensive genetic profile for CYP2C19 and CYP2C9. The patient was treated with a therapeutic dose of VRZ but developed a neurotoxicity leading to hallucinations and coma while the plasma concentration of VRZ reached an exceptional level (20.0 µg/mL on day 10 of the treatment). Since neurological disorders diminished in parallel with the decrease of VRZ plasma concentrations, the coma was likely due to VRZ. The VRZ half-life, calculated to 58 h in this patient, was by far higher than the values reported in the literature. While VRZ concentrations slowly decreased, the N-oxide voriconazole concentrations slowly increased from day 15. Hypotheses for this lack of metabolization of VRZ are an inhibition of the metabolism by esomeprazole, a saturation of the metabolism or an enzymatic auto-inhibition of VRZ metabolism but none of these hypotheses have yet been explored. This case-report of unpredictable accumulation of VRZ in a patient without any genetic risk factor is an advocacy for systematic therapeutic drug monitoring of VRZ.
Cited literature [19 references]
https://hal-univ-rennes1.archives-ouvertes.fr/hal-00910224
Contributor : Marie Lecoupe-Grainville <>
Submitted on : Wednesday, November 27, 2013 - 4:02:22 PM
Last modification on : Thursday, January 14, 2021 - 11:17:13 AM
Long-term archiving on: : Friday, February 28, 2014 - 8:05:09 AM
Contributor : Marie Lecoupe-Grainville <>
Submitted on : Wednesday, November 27, 2013 - 4:02:22 PM
Last modification on : Thursday, January 14, 2021 - 11:17:13 AM
Long-term archiving on: : Friday, February 28, 2014 - 8:05:09 AM
File
28_DMPK-13-NT-007.pdf
Publisher files allowed on an open archive